BML, Inc. operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML with three other
pharmaceutical manufacturers in Asia:
Sogo Clinical Holdings Co.Limited.
sales of 6.77 billion Japanese Yen [US$65.96 million]
Medical & Biological Laboratories Company Limited
(6.92 billion Japanese Yen [US$67.51 million]
of which 100%
was Reagent business), and
Falco Sd Holdings Company Limited
(62.76 billion Japanese Yen [US$611.89 million]
of which 47%
was Medical Test).
BML reported sales of ¥94.61 billion (US$922.43 million)
March of 2013.
increase of 2.6%
versus 2012, when the company's sales were ¥92.20 billion.
Sales at BML have increased during each of the previous five years
(and since 2008, sales have increased a total of 30%).
Sales of Related Businesses saw an increase
that was more than double the company's growth rate: sales were up
8.2% in 2013, from
¥219.00 million to ¥237.00 million.
Not all segments of BML experienced an increase in sales in 2013:
sales of Medical Information fell 0.8% to ¥3.23 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).